Key facts
- It has raised $990K; the latest was Later Stage VC ($100K) in Apr 2026.
- Notable investors include Plug and Play Tech Center, KOFA Healthcare, Minnesota Department of Employment and Economic Development.
- Marrow Access Technologies has filed 1 Form D with the SEC, most recently Jun 2024 ($241K sold to 2 investors).
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Marrow Access Technologies
- ·The full record, as it builds
Funding rounds
No funding rounds for Marrow Access Technologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Marrow Access Technologies
Developer of orthopedic surgical devices designed for marrow stimulation therapy. The company's devices utilize a patented mechanism to create clean, deep, precise channels into the bone to stimulate the patient's healing reaction to repair and regenerate cartilage and other soft tissue, enabling healthcare professionals to help with cartilage defects to heal the bones in a less invasive way.
- Sector
- Healthcare
- HQ
- Eden Prairie, MN, United States
- Founded
- 2017
- Employees
- 7
- Website
- marrowaccess.com/
- Ownership
- Privately Held (backing)
Marrow Access Technologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Marrow Access Technologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Marrow Access Technologies in its N-PORT filings yet. We sweep new filings monthly.